{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T13:06:57Z","timestamp":1793970417793,"version":"4.8.0"},"reference-count":129,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-15030-8","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T08:48:28Z","timestamp":1759308508000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Structural and energetic basis of marine phytochemicals as dengue NS1 protein inhibitors"],"prefix":"10.1038","volume":"15","author":[{"given":"Sanjida Mahjabin","family":"Sanju","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Meherajul","family":"Kabir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Ifteker","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahamad Arafat","family":"Rizbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehajabin Nusrat","family":"Nadia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jannatul","family":"Ferdous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mst. Ruma","family":"Akter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazia","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhana Mansoor","family":"Priya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noimul Hasan","family":"Siddiquee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,1]]},"reference":[{"key":"15030_CR1","doi-asserted-by":"publisher","first-page":"4828","DOI":"10.1371\/journal.pntd.0004828","volume":"10","author":"HR Chen","year":"2016","unstructured":"Chen, H. R. et al. Dengue virus nonstructural protein 1 induces vascular leakage through macrophage migration inhibitory factor and autophagy. PLoS Negl. Trop. Dis. 10, 4828 (2016).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"15030_CR2","doi-asserted-by":"publisher","first-page":"866452","DOI":"10.3389\/fcimb.2022.866452","volume":"12","author":"K Alagarasu","year":"2022","unstructured":"Alagarasu, K. et al. In vitro antiviral activity of potential medicinal plant extracts against dengue and Chikungunya viruses. Front. Cell. Infect. Microbiol. 12, 866452 (2022).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"15030_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcimb.2023.1061937","volume":"13","author":"H Norshidah","year":"2023","unstructured":"Norshidah, H. et al. Assessing the potential of NS2B\/NS3 protease inhibitors biomarker in curbing dengue virus infections: In silico vs In vitro approach. Front. Cell. Infect. Microbiol. 13, 1\u201317 (2023).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"15030_CR4","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.3390\/v15051102","volume":"15","author":"BEK Tan","year":"2023","unstructured":"Tan, B. E. K., Beard, M. R. & Eyre, N. S. Identification of key residues in dengue virus NS1 protein that are essential for its secretion. Viruses 15, 1102 (2023).","journal-title":"Viruses"},{"key":"15030_CR5","doi-asserted-by":"publisher","first-page":"20191548","DOI":"10.1084\/jem.20191548","volume":"217","author":"PX Lee","year":"2020","unstructured":"Lee, P. X. et al. Relative contribution of nonstructural protein 1 in dengue pathogenesis. J. Exp. Med. 217, 20191548 (2020).","journal-title":"J. Exp. Med."},{"key":"15030_CR6","doi-asserted-by":"publisher","first-page":"199018","DOI":"10.1016\/j.virusres.2022.199018","volume":"324","author":"BH Kok","year":"2023","unstructured":"Kok, B. H. et al. Dengue virus infection \u2013 a review of pathogenesis, vaccines, diagnosis and therapy. Virus Res. 324, 199018 (2023).","journal-title":"Virus Res."},{"key":"15030_CR7","doi-asserted-by":"publisher","first-page":"156","DOI":"10.4103\/0972-9062.184848","volume":"53","author":"VD Dwivedi","year":"2016","unstructured":"Dwivedi, V. D., Tripathi, I. P. & Mishra, S. K. In silico evaluation of inhibitory potential of triterpenoids from azadirachta indica against therapeutic target of dengue virus, NS2B-NS3 protease. J. Vector Borne Dis. 53, 156\u2013161 (2016).","journal-title":"J. Vector Borne Dis."},{"key":"15030_CR8","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nature12060","volume":"496","author":"S Bhatt","year":"2013","unstructured":"Bhatt, S. et al. The global distribution and burden of dengue. Nature 496, 504\u2013507 (2013).","journal-title":"Nature"},{"key":"15030_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/psp4.13233","author":"J Ding","year":"2024","unstructured":"Ding, J. et al. In-host modeling of dengue virus and non-structural protein 1 and the effects of ivermectin in patients with acute dengue fever. CPT Pharmacometrics Syst. Pharmacol. https:\/\/doi.org\/10.1002\/psp4.13233 (2024).","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"15030_CR10","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12985-016-0590-7","volume":"13","author":"M Rastogi","year":"2016","unstructured":"Rastogi, M., Sharma, N. & Singh, S. K. Flavivirus NS1: a multifaceted enigmatic viral protein. Virol. J. 13, 131 (2016).","journal-title":"Virol. J."},{"key":"15030_CR11","doi-asserted-by":"publisher","unstructured":"Avirutnan, P. et al. Secreted NS1 of Dengue Virus Attaches to the Surface of Cells via Interactions with Heparan Sulfate and Chondroitin Sulfate E. https:\/\/doi.org\/10.1371\/journal.ppat.0030183.","DOI":"10.1371\/journal.ppat.0030183"},{"key":"15030_CR12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1146\/annurev.micro.62.081307.163005","volume":"62","author":"JL Kyle","year":"2008","unstructured":"Kyle, J. L. & Harris, E. Global spread and persistence of dengue. Annu. Rev. Microbiol. 62, 71\u201392 (2008).","journal-title":"Annu. Rev. Microbiol."},{"key":"15030_CR13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.meegid.2011.10.012","volume":"12","author":"KS Lee","year":"2012","unstructured":"Lee, K. S. et al. Dengue virus surveillance in Singapore reveals high viral diversity through multiple introductions and in situ evolution. Infect. Genet. Evol. 12, 77\u201385 (2012).","journal-title":"Infect. Genet. Evol."},{"key":"15030_CR14","doi-asserted-by":"publisher","first-page":"17992","DOI":"10.1073\/pnas.2003056117","volume":"117","author":"H Xia","year":"2020","unstructured":"Xia, H. et al. A cocrystal structure of dengue capsid protein in complex of inhibitor. Proc. Natl. Acad. Sci. U. S. A. 117, 17992\u201318001 (2020).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"15030_CR15","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12929-024-01077-8","volume":"31","author":"S Dayarathna","year":"2024","unstructured":"Dayarathna, S. et al. Dengue NS1 interaction with lipids alters its pathogenic effects on monocyte derived macrophages. J. Biomed. Sci. 31, 86 (2024).","journal-title":"J. Biomed. Sci."},{"key":"15030_CR16","doi-asserted-by":"publisher","first-page":"4738","DOI":"10.1128\/JVI.73.6.4738-4747.1999","volume":"73","author":"KC Leitmeyer","year":"1999","unstructured":"Leitmeyer, K. C. et al. Dengue virus structural differences that correlate with pathogenesis. J. Virol. 73, 4738\u20134747 (1999).","journal-title":"J. Virol."},{"key":"15030_CR17","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.3389\/fimmu.2019.01651","volume":"10","author":"A Reyes-Sandoval","year":"2019","unstructured":"Reyes-Sandoval, A. & Ludert, J. E. The dual role of the antibody response against the flavivirus non-structural protein 1 (NS1) in protection and immuno-pathogenesis. Front. Immunol. 10, 1651 (2019).","journal-title":"Front. Immunol."},{"key":"15030_CR18","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1146\/annurev-virology-101416-041848","volume":"5","author":"DR Glasner","year":"2018","unstructured":"Glasner, D. R., Puerta-Guardo, H., Beatty, P. R. & Harris, E. The Good, the Bad, and the Shocking: The Multiple Roles of Dengue Virus Nonstructural Protein 1 in Protection and Pathogenesis. Annu. Rev. Virol. 5, 227 (2018).","journal-title":"Annu. Rev. Virol."},{"key":"15030_CR19","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.virol.2011.02.022","volume":"413","author":"P Somnuke","year":"2011","unstructured":"Somnuke, P., Hauhart, R. E., Atkinson, J. P., Diamond, M. S. & Avirutnan, P. N-linked glycosylation of dengue virus NS1 protein modulates secretion, cell-surface expression, hexamer stability, and interactions with human complement. Virology 413, 253\u2013264 (2011).","journal-title":"Virology"},{"key":"15030_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11010227","author":"R Sootichote","year":"2023","unstructured":"Sootichote, R. et al. Potential protective effect of dengue NS1 human monoclonal antibodies against dengue and Zika virus infections. Biomedicines https:\/\/doi.org\/10.3390\/biomedicines11010227 (2023).","journal-title":"Biomedicines"},{"key":"15030_CR21","doi-asserted-by":"publisher","first-page":"4277","DOI":"10.1371\/journal.pntd.0004277","volume":"9","author":"AJS Gon\u00e7alves","year":"2015","unstructured":"Gon\u00e7alves, A. J. S. et al. Cooperation between CD4+ T cells and humoral immunity is critical for protection against dengue using a DNA vaccine based on the NS1 antigen. PLoS Negl. Trop. Dis. 9, 4277 (2015).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"15030_CR22","doi-asserted-by":"publisher","first-page":"12933","DOI":"10.1038\/s41598-020-69515-9","volume":"10","author":"P Songprakhon","year":"2020","unstructured":"Songprakhon, P. et al. Peptides targeting dengue viral nonstructural protein 1 inhibit dengue virus production. Sci. Rep. 10, 12933 (2020).","journal-title":"Sci. Rep."},{"key":"15030_CR23","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1006\/viro.1996.0307","volume":"220","author":"JM Mackenzie","year":"1996","unstructured":"Mackenzie, J. M., Jones, M. K. & Young, P. R. Immunolocalization of the dengue virus nonstructural glycoprotein NS1 suggests a role in viral RNA replication. Virology 220, 232\u2013240 (1996).","journal-title":"Virology"},{"key":"15030_CR24","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1084\/jem.20092545","volume":"207","author":"P Avirutnan","year":"2010","unstructured":"Avirutnan, P. et al. Antagonism of the complement component C4 by flavivirus nonstructural protein NS1. J. Exp. Med. 207, 793\u2013806 (2010).","journal-title":"J. Exp. Med."},{"key":"15030_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-024-65593-1","volume":"14","author":"S Nasar","year":"2024","unstructured":"Nasar, S., Iftikhar, S., Saleem, R., Nadeem, M. S. & Ali, M. The N and C-terminal deleted variant of the dengue virus NS1 protein is a potential candidate for dengue vaccine development. Sci. Rep. 14, 1\u201311 (2024).","journal-title":"Sci. Rep."},{"key":"15030_CR26","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1126\/scitranslmed.aaa3863","volume":"7","author":"N Modhiran","year":"2015","unstructured":"Modhiran, N. et al. Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity. Sci. Transl. Med. 7, 142 (2015).","journal-title":"Sci. Transl. Med."},{"key":"15030_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007625","volume":"15","author":"CH Chao","year":"2019","unstructured":"Chao, C. H. et al. Dengue virus nonstructural protein 1 activates platelets via Toll-like receptor 4, leading to thrombocytopenia and hemorrhage. PLOS Pathog. 15, e1007625 (2019).","journal-title":"PLOS Pathog."},{"key":"15030_CR28","doi-asserted-by":"publisher","first-page":"20312","DOI":"10.7189\/jogh.08.020312","volume":"8","author":"K Fatima","year":"2018","unstructured":"Fatima, K. & Syed, N. I. Dengvaxia controversy: Impact on vaccine hesitancy. J. Glob. Health 8, 20312 (2018).","journal-title":"J. Glob. Health"},{"key":"15030_CR29","doi-asserted-by":"publisher","first-page":"12933","DOI":"10.1038\/s41598-020-69515-9","volume":"10","author":"P Songprakhon","year":"2020","unstructured":"Songprakhon, P. et al. Peptides targeting dengue viral nonstructural protein 1 inhibit dengue virus production. Sci. Rep. 10, 12933 (2020).","journal-title":"Sci. Rep."},{"key":"15030_CR30","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.antiviral.2013.03.008","volume":"98","author":"DA Muller","year":"2013","unstructured":"Muller, D. A. & Young, P. R. The flavivirus NS1 protein: molecular and structural biology, immunology, role in pathogenesis and application as a diagnostic biomarker. Antiviral Res. 98, 192\u2013208 (2013).","journal-title":"Antiviral Res."},{"key":"15030_CR31","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1126\/scitranslmed.aaa3787","volume":"7","author":"PR Beatty","year":"2015","unstructured":"Beatty, P. R. et al. Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination. Sci. Transl. Med. 7, 141 (2015).","journal-title":"Sci. Transl. Med."},{"key":"15030_CR32","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2147\/IDR.S22613","volume":"5","author":"S Rajapakse","year":"2012","unstructured":"Rajapakse, S., Rodrigo, C. & Rajapakse, A. Treatment of dengue fever. Infect. Drug Resist. 5, 103 (2012).","journal-title":"Infect. Drug Resist."},{"key":"15030_CR33","unstructured":"Dengue and severe dengue. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dengue-and-severe-dengue."},{"key":"15030_CR34","unstructured":"National Instite of Diabetes en Digestive and Kidney Diseases. Acetaminophen. LiverTox Clin. Res. Inf. Drug-Induced Liver Inj. (2016)."},{"key":"15030_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2564","volume":"34","author":"V Campana","year":"2024","unstructured":"Campana, V. et al. Liver involvement in dengue: A systematic review. Rev. Med. Virol. 34, e2564 (2024).","journal-title":"Rev. Med. Virol."},{"issue":"Suppl 3","key":"15030_CR36","first-page":"S363","volume":"88","author":"S Simasathien","year":"2005","unstructured":"Simasathien, S. & Watanaveeradej, V. Dengue vaccine. J. Med. Assoc. Thai. 88(Suppl 3), S363\u2013S377 (2005).","journal-title":"J. Med. Assoc. Thai."},{"key":"15030_CR37","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1056\/NEJMoa1800820","volume":"379","author":"S Sridhar","year":"2018","unstructured":"Sridhar, S. et al. Effect of dengue serostatus on dengue vaccine safety and efficacy. N. Engl. J. Med. 379, 327\u2013340 (2018).","journal-title":"N. Engl. J. Med."},{"key":"15030_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvacx.2024.100604","volume":"22","author":"MF Lee","year":"2025","unstructured":"Lee, M. F., Long, C. M. & Poh, C. L. Current status of the development of dengue vaccines. Vaccine X 22, 100604 (2025).","journal-title":"Vaccine X"},{"key":"15030_CR39","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1002\/hsr2.2170","volume":"7","author":"I Ahmed","year":"2024","unstructured":"Ahmed, I., Ahamed, R., Nahar, S. & Bari, L. F. Immunization against dengue virus infection is coercive: A timely call. Health Sci. Reports 7, 2170. https:\/\/doi.org\/10.1002\/hsr2.2170 (2024).","journal-title":"Health Sci. Reports"},{"key":"15030_CR40","unstructured":"Vaccines and immunization: Dengue. https:\/\/www.who.int\/news-room\/questions-and-answers\/item\/dengue-vaccines."},{"key":"15030_CR41","unstructured":"Dengue Tetravalent Vaccine (Live, Attenuated) Takeda - opinion on medicine for use outside EU | European Medicines Agency (EMA). https:\/\/www.ema.europa.eu\/en\/opinion-medicine-use-outside-EU\/human\/dengue-tetravalent-vaccine-live-attenuated-takeda."},{"key":"15030_CR42","doi-asserted-by":"publisher","first-page":"126407","DOI":"10.1016\/j.vaccine.2024.126407","volume":"42","author":"J Percio","year":"2024","unstructured":"Percio, J. et al. Safety signal detected: Anaphylaxis after attenuated dengue vaccine (TAK-003) - Brazil, march 1, 2023-march 11, 2024. Vaccine 42, 126407 (2024).","journal-title":"Vaccine"},{"key":"15030_CR43","unstructured":"Qdenga | European Medicines Agency (EMA). https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/qdenga?utm."},{"key":"15030_CR44","doi-asserted-by":"publisher","DOI":"10.1172\/JCI173328","volume":"134","author":"KK Pierce","year":"2024","unstructured":"Pierce, K. K. et al. TV005 dengue vaccine protects against dengue serotypes 2 and 3 in two controlled human infection studies. J. Clin. Invest. 134, e173328 (2024).","journal-title":"J. Clin. Invest."},{"key":"15030_CR45","unstructured":"Dengue Vaccines \u2014 Vax-Before-Travel. https:\/\/www.vax-before-travel.com\/dengue-vaccines."},{"key":"15030_CR46","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/S1473-3099(23)00520-0","volume":"24","author":"MCR Walsh","year":"2024","unstructured":"Walsh, M. C. R. et al. Safety and durable immunogenicity of the TV005 tetravalent dengue vaccine, across serotypes and age groups, in dengue-endemic Bangladesh: a randomised, controlled trial. Lancet. Infect. Dis. 24, 150\u2013160 (2024).","journal-title":"Lancet. Infect. Dis."},{"key":"15030_CR47","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s000180050138","volume":"54","author":"M Laille","year":"1998","unstructured":"Laille, M., Gerald, F. & Debitus, C. In vitro antiviral activity on dengue virus of marine natural products. Cell. Mol. Life Sci. 54, 167\u2013170 (1998).","journal-title":"Cell. Mol. Life Sci."},{"key":"15030_CR48","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3390\/md16070229","volume":"16","author":"DL Wu","year":"2018","unstructured":"Wu, D. L. et al. Polyketides and alkaloids from the marine-derived fungus Dichotomomyces cejpii F31\u20131 and the antiviral activity of scequinadoline A against dengue virus. Mar. Drugs 16, 229 (2018).","journal-title":"Mar. Drugs"},{"key":"15030_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.biteb.2020.100623","volume":"13","author":"N Hans","year":"2021","unstructured":"Hans, N., Malik, A. & Naik, S. Antiviral activity of sulfated polysaccharides from marine algae and its application in combating COVID-19: Mini review. Bioresour Technol. Reports 13, 100623 (2021).","journal-title":"Bioresour Technol. Reports"},{"key":"15030_CR50","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3390\/md20060385","volume":"20","author":"S Lomartire","year":"2022","unstructured":"Lomartire, S. & Gon\u00e7alves, A. M. M. Antiviral activity and mechanisms of seaweeds bioactive compounds on enveloped viruses\u2014a review. Mar. Drugs 20, 385 (2022).","journal-title":"Mar. Drugs"},{"key":"15030_CR51","doi-asserted-by":"publisher","first-page":"4285","DOI":"10.3390\/molecules28114285","volume":"28","author":"GS dos Santos","year":"2023","unstructured":"dos Santos, G. S. et al. Seaweeds and Corals from the Brazilian Coast: Review on biotechnological potential and environmental aspects. Molecules 28, 4285 (2023).","journal-title":"Molecules"},{"key":"15030_CR52","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3390\/md19050245","volume":"19","author":"S Lomartire","year":"2021","unstructured":"Lomartire, S. et al. Environmental impact on seaweed phenolic production and activity: An important step for compound exploitation. Mar. Drugs 19, 245 (2021).","journal-title":"Mar. Drugs"},{"key":"15030_CR53","doi-asserted-by":"publisher","first-page":"9424","DOI":"10.1080\/07391102.2022.2141895","volume":"41","author":"B Sharma","year":"2023","unstructured":"Sharma, B., Bhattacherjee, D., Zyryanov, G. V. & Purohit, R. An insight from computational approach to explore novel, high-affinity phosphodiesterase 10A inhibitors for neurological disorders. J. Biomol. Struct. Dyn. 41, 9424\u20139436 (2023).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"15030_CR54","doi-asserted-by":"publisher","first-page":"151614","DOI":"10.1016\/j.bbrc.2025.151614","volume":"758","author":"B Sharma","year":"2025","unstructured":"Sharma, B. & Purohit, R. Enhanced sampling simulations to explore himalayan phytochemicals as potential phosphodiesterase-1 inhibitor for neurological disorders. Biochem. Biophys. Res. Commun. 758, 151614 (2025).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"15030_CR55","first-page":"2711","volume":"34","author":"N Kalsi","year":"2016","unstructured":"Kalsi, N., Gopalakrishnan, C., Rajendran, V. & Purohit, R. Biophysical aspect of phosphatidylinositol 3-kinase and role of oncogenic mutants (E542K & E545K). J. Biomol. Struct. Dyn. 34, 2711\u20132721 (2016).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"15030_CR56","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1080\/07391102.2013.770373","volume":"32","author":"A Kumar","year":"2014","unstructured":"Kumar, A., Rajendran, V., Sethumadhavan, R. & Purohit, R. Relationship between a point mutation S97C in CK1\u03b4 protein and its affect on ATP-binding affinity. J. Biomol. Struct. Dyn. 32, 394\u2013405 (2014).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"15030_CR57","doi-asserted-by":"publisher","first-page":"5587","DOI":"10.1007\/s00894-013-2044-0","volume":"19","author":"B Kamaraj","year":"2013","unstructured":"Kamaraj, B., Rajendran, V., Sethumadhavan, R. & Purohit, R. In-silico screening of cancer associated mutation on PLK1 protein and its structural consequences. J. Mol. Model. 19, 5587\u20135599 (2013).","journal-title":"J. Mol. Model."},{"key":"15030_CR58","unstructured":"Drug Toxicity - an overview | ScienceDirect Topics. https:\/\/www.sciencedirect.com\/topics\/pharmacology-toxicology-and-pharmaceutical-science\/drug-toxicity."},{"key":"15030_CR59","doi-asserted-by":"publisher","first-page":"101511","DOI":"10.1016\/j.cegh.2024.101511","volume":"28","author":"S Basu","year":"2024","unstructured":"Basu, S., Veeraraghavan, B. & Anbarasu, A. Anti-bacterial compounds from Indian curry-leaf tree Murraya koenigii have potential to inhibit carbapenem-resistant Streptococcus pneumoniae. Clin. Epidemiol. Glob. Heal. 28, 101511 (2024).","journal-title":"Clin. Epidemiol. Glob. Heal."},{"key":"15030_CR60","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1177\/1747519820932091","volume":"45","author":"M Miar","year":"2021","unstructured":"Miar, M., Shiroudi, A., Pourshamsian, K., Oliaey, A. R. & Hatamjafari, F. Theoretical investigations on the HOMO\u2013LUMO gap and global reactivity descriptor studies, natural bond orbital, and nucleus-independent chemical shifts analyses of 3-phenylbenzo[d]thiazole-2(3H)-imine and its para-substituted derivatives: Solvent and substituent effects. J. Chem. Res. 45, 147\u2013158 (2021).","journal-title":"J. Chem. Res."},{"key":"15030_CR61","doi-asserted-by":"publisher","first-page":"117793222412641","DOI":"10.1177\/11779322241264145","volume":"18","author":"O Saha","year":"2024","unstructured":"Saha, O. et al. Antiviral activity, pharmacoinformatics, molecular docking, and dynamics studies of Azadirachta indica Against Nipah virus by targeting envelope glycoprotein: Emerging strategies for developing antiviral treatment. Bioinform. Biol. Insights 18, 11779322241264144 (2024).","journal-title":"Bioinform. Biol. Insights"},{"key":"15030_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.imu.2024.101486","volume":"47","author":"NH Siddiquee","year":"2024","unstructured":"Siddiquee, N. H. et al. Unveiling the antiviral activity of 2\u2032,3,5,7-Tetrahydroxyflavanone as potential inhibitor of chikungunya virus envelope glycoprotein. Inform. Med. Unlocked 47, 101486 (2024).","journal-title":"Inform. Med. Unlocked"},{"key":"15030_CR63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0310802","volume":"19","author":"NH Siddiquee","year":"2024","unstructured":"Siddiquee, N. H. et al. Nature\u2019s defense against emerging neurodegenerative threats: Dynamic simulation, PCA, DCCM identified potential plant-based antiviral lead targeting borna disease virus nucleoprotein. PLoS ONE 19, e0310802 (2024).","journal-title":"PLoS ONE"},{"key":"15030_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.imu.2024.101458","volume":"45","author":"NH Siddiquee","year":"2024","unstructured":"Siddiquee, N. H. et al. In-silico identification of novel natural drug leads against the Ebola virus VP40 protein: A promising approach for developing new antiviral therapeutics. Inform. Med. Unlocked 45, 101458 (2024).","journal-title":"Inform. Med. Unlocked"},{"key":"15030_CR65","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.3390\/ph17121617","volume":"17","author":"AM Hassan","year":"2024","unstructured":"Hassan, A. M. et al. Evaluating the binding potential and stability of drug-like compounds with the Monkeypox Virus VP39 protein using molecular dynamics simulations and free energy analysis. Pharmaceuticals 17, 1617 (2024).","journal-title":"Pharmaceuticals"},{"key":"15030_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2025.110199","volume":"191","author":"Y Boulaamane","year":"2025","unstructured":"Boulaamane, Y. et al. Computational screening of natural products as tryptophan 2,3-dioxygenase inhibitors: Insights from CNN-based QSAR, molecular docking, ADMET, and molecular dynamics simulations. Comput. Biol. Med. 191, 110199 (2025).","journal-title":"Comput. Biol. Med."},{"key":"15030_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2024.139924","volume":"1321","author":"MEK Talukder","year":"2025","unstructured":"Talukder, M. E. K. et al. Molecular docking, QSAR, and simulation analyses of EGFR-targeting phytochemicals in non-small cell lung cancer. J. Mol. Struct. 1321, 139924 (2025).","journal-title":"J. Mol. Struct."},{"key":"15030_CR68","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.3390\/ani14091283","volume":"14","author":"S Zia","year":"2024","unstructured":"Zia, S. et al. Potential inhibitors of lumpy skin disease\u2019s viral protein (DNA polymerase): A combination of bioinformatics approaches. Animals 14, 1283 (2024).","journal-title":"Animals"},{"key":"15030_CR69","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/cbdv.202401987","volume":"1","author":"NH Siddiquee","year":"2025","unstructured":"Siddiquee, N. H. et al. Natural products in precision neurological disease (Cryptococcal Meningitis): Structure-based phytochemical screening of Glycyrrhiza glabra plant against cryptococcus neoformans farnesyltransferase (FTase). Chem. Biodivers. 1, 17. https:\/\/doi.org\/10.1002\/cbdv.202401987 (2025).","journal-title":"Chem. Biodivers."},{"key":"15030_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2024.105710","volume":"127","author":"M Pourzangiabadi","year":"2025","unstructured":"Pourzangiabadi, M., Najafi, H., Fallah, A., Goudarzi, A. & Pouladi, I. Dengue virus: Etiology, epidemiology, pathobiology, and developments in diagnosis and control \u2013 A comprehensive review. Infect. Genet. Evol. 127, 105710 (2025).","journal-title":"Infect. Genet. Evol."},{"key":"15030_CR71","unstructured":"Evaluation of blockbuster drugs under the rule-of-five - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/20225662\/."},{"key":"15030_CR72","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.3389\/fmicb.2019.02470","volume":"10","author":"NJ Sadgrove","year":"2019","unstructured":"Sadgrove, N. J. & Jones, G. L. From petri dish to patient: Bioavailability estimation and mechanism of action for antimicrobial and immunomodulatory natural products. Front. Microbiol. 10, 2470 (2019).","journal-title":"Front. Microbiol."},{"key":"15030_CR73","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","volume":"1","author":"CA Lipinski","year":"2004","unstructured":"Lipinski, C. A. Lead- and drug-like compounds: The rule-of-five revolution. Drug Discov. Today Technol. 1, 337\u2013341 (2004).","journal-title":"Drug Discov. Today Technol."},{"key":"15030_CR74","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0321902","volume":"20","author":"NH Siddiquee","year":"2025","unstructured":"Siddiquee, N. H. et al. Molecular activity of bioactive phytocompounds for inhibiting host cell attachment and membrane fusion interacting with West Nile Virus envelope glycoprotein. PLoS ONE 20, e0321902 (2025).","journal-title":"PLoS ONE"},{"key":"15030_CR75","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.2174\/1568026616666161117112604","volume":"17","author":"X Zhang","year":"2017","unstructured":"Zhang, X., Perez-Sanchez, H. & Lightstone, C. F. A. Comprehensive docking and MM\/GBSA rescoring study of ligand recognition upon binding antithrombin. Curr. Top. Med. Chem. 17, 1631\u20131639 (2017).","journal-title":"Curr. Top. Med. Chem."},{"key":"15030_CR76","doi-asserted-by":"publisher","first-page":"6","DOI":"10.59298\/JCAS\/2024\/91.6109000","volume":"9","author":"OA Regina","year":"2024","unstructured":"Regina, O. A. Quantum mechanical methods in computational chemistry. Idosr J. Comput. Appl. Sci. 9, 6\u201310 (2024).","journal-title":"Idosr J. Comput. Appl. Sci."},{"key":"15030_CR77","first-page":"2169","volume":"24","author":"SC J\u00e1afaru","year":"2024","unstructured":"J\u00e1afaru, S. C. et al. In-silico exploration and structure-based design of Praziquantel derivatives as potential inhibitors of schistosoma mansoni Glutathione S-transferase (SmGST). Sci. African 24, 2169 (2024).","journal-title":"Sci. African"},{"key":"15030_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.rechem.2024.101437","volume":"7","author":"V Hadigheh Rezvan","year":"2024","unstructured":"Hadigheh Rezvan, V. Molecular structure, HOMO\u2013LUMO, and NLO studies of some quinoxaline 1,4-dioxide derivatives: Computational (HF and DFT) analysis. Results Chem. 7, 101437 (2024).","journal-title":"Results Chem."},{"key":"15030_CR79","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1039\/C9NJ04909F","volume":"44","author":"S Chtita","year":"2020","unstructured":"Chtita, S. et al. QSAR study of N -substituted oseltamivir derivatives as potent avian influenza virus H5N1 inhibitors using quantum chemical descriptors and statistical methods. New J. Chem. 44, 1747\u20131760 (2020).","journal-title":"New J. Chem."},{"key":"15030_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e16222","volume":"9","author":"M Alam","year":"2023","unstructured":"Alam, M. et al. Synthesis, characterization, antibacterial activity of thiosemicarbazones derivatives and their computational approaches: Quantum calculation, molecular docking, molecular dynamic, ADMET. QSAR. Heliyon 9, e16222 (2023).","journal-title":"QSAR. Heliyon"},{"key":"15030_CR81","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1042\/BJ20051069","volume":"392","author":"S Harada","year":"2005","unstructured":"Harada, S. The broad anti-viral agent glycyrrhizin directly modulates the fluidity of plasma membrane and HIV-1 envelope. Biochem. J. 392, 191\u2013199 (2005).","journal-title":"Biochem. J."},{"key":"15030_CR82","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.3390\/v12101141","volume":"12","author":"J Wang","year":"2020","unstructured":"Wang, J., Prinz, R. A., Liu, X. & Xu, X. In vitro and in vivo antiviral activity of gingerenone a on influenza a virus is mediated by targeting Janus Kinase 2. Viruses 12, 1141 (2020).","journal-title":"Viruses"},{"key":"15030_CR83","doi-asserted-by":"publisher","first-page":"361","DOI":"10.6026\/97320630005361","volume":"5","author":"GDJ Davis","year":"2011","unstructured":"Davis, G. D. J. & Vasanthi, A. H. R. Seaweed metabolite database (SWMD): A database of natural compounds from marine algae. Bioinformation 5, 361\u2013364 (2011).","journal-title":"Bioinformation"},{"key":"15030_CR84","doi-asserted-by":"publisher","first-page":"9916","DOI":"10.1021\/jf2022447","volume":"59","author":"K Li","year":"2011","unstructured":"Li, K., Li, X. M., Gloer, J. B. & Wang, B. G. Isolation, characterization, and antioxidant activity of bromophenols of the marine red alga Rhodomela confervoides. J. Agric. Food Chem. 59, 9916\u20139921 (2011).","journal-title":"J. Agric. Food Chem."},{"key":"15030_CR85","doi-asserted-by":"publisher","first-page":"962S","DOI":"10.1093\/jn\/127.5.962S","volume":"127","author":"E Peterhans","year":"1997","unstructured":"Peterhans, E. Oxidants and antioxidants in viral diseases: Disease mechanisms and metabolic regulation. J. Nutr. 127, 962S-965S (1997).","journal-title":"J. Nutr."},{"key":"15030_CR86","unstructured":"WoRMS - World Register of Marine Species - Rhodomela confervoides (Hudson) P.C.Silva, 1952. https:\/\/www.marinespecies.org\/aphia.php?p=taxdetails&id=144854."},{"key":"15030_CR87","doi-asserted-by":"publisher","first-page":"31","DOI":"10.29161\/PT.v6.i10.2018.31","volume":"6","author":"B Sathyamurthy","year":"2018","unstructured":"Sathyamurthy, B. & Sushmitha, H. S. In Silico drug designing studies on dengue virus NS1 protein. PharmaTutor 6, 31 (2018).","journal-title":"PharmaTutor"},{"key":"15030_CR88","doi-asserted-by":"publisher","DOI":"10.1590\/s2175-97902020000117420","volume":"56","author":"I Qaddir","year":"2020","unstructured":"Qaddir, I., Majeed, A., Hussain, W., Mahmood, S. & Rasool, N. An in silico investigation of phytochemicals as potential inhibitors against non-structural protein 1 from dengue virus 4. Brazilian J. Pharm. Sci. 56, e17420 (2020).","journal-title":"Brazilian J. Pharm. Sci."},{"key":"15030_CR89","doi-asserted-by":"publisher","first-page":"51089","DOI":"10.1371\/journal.pone.0051089","volume":"7","author":"AC Koishi","year":"2012","unstructured":"Koishi, A. C. et al. Screening of dengue virus antiviral activity of marine seaweeds by an in situ enzyme-linked immunosorbent assay. PLoS ONE 7, 51089 (2012).","journal-title":"PLoS ONE"},{"issue":"343","key":"15030_CR90","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1126\/science.1247749","volume":"80","author":"DL Akey","year":"2014","unstructured":"Akey, D. L. et al. Flavivirus NS1 structures reveal surfaces for associations with membranes and the immune system. Science 80(343), 881\u2013885 (2014).","journal-title":"Science"},{"key":"15030_CR91","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","volume":"27","author":"G MadhaviSastry","year":"2013","unstructured":"MadhaviSastry, G., Adzhigirey, M. & Day, T. Annabhimoju, R. & Sherman, W. Protein and ligand preparation: Parameters, protocols, and influence on virtual screening enrichments. J. Comput. Aided. Mol. Des. 27, 221\u2013234 (2013).","journal-title":"J. Comput. Aided. Mol. Des."},{"key":"15030_CR92","doi-asserted-by":"publisher","first-page":"4291","DOI":"10.1021\/acs.jctc.1c00302","volume":"17","author":"C Lu","year":"2021","unstructured":"Lu, C. et al. OPLS4: improving force field accuracy on challenging regimes of chemical space. J. Chem. Theory Comput. 17, 4291\u20134300 (2021).","journal-title":"J. Chem. Theory Comput."},{"key":"15030_CR93","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s10822-007-9133-z","volume":"21","author":"JC Shelley","year":"2007","unstructured":"Shelley, J. C. et al. Epik: A software program for pKa prediction and protonation state generation for drug-like molecules. J. Comput. Aided. Mol. Des. 21, 681\u2013691 (2007).","journal-title":"J. Comput. Aided. Mol. Des."},{"key":"15030_CR94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/bib\/bbab098","volume":"22","author":"F Ahammad","year":"2021","unstructured":"Ahammad, F. et al. Pharmacoinformatics and molecular dynamics simulation-based phytochemical screening of neem plant (Azadiractha indica) against human cancer by targeting MCM7 protein. Brief. Bioinform. 22, 1\u201315 (2021).","journal-title":"Brief. Bioinform."},{"key":"15030_CR95","doi-asserted-by":"publisher","first-page":"117793222412641","DOI":"10.1177\/11779322241264145","volume":"18","author":"O Saha","year":"2024","unstructured":"Saha, O. et al. Antiviral activity, pharmacoinformatics, molecular docking, and dynamics studies of Azadirachta indica against Nipah virus by targeting envelope glycoprotein: Emerging strategies for developing antiviral treatment. Bioinform. Biol. Insights 18, 11779322241264144 (2024).","journal-title":"Bioinform. Biol. Insights"},{"key":"15030_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2022.106279","volume":"151","author":"R Debroy","year":"2022","unstructured":"Debroy, R. & Ramaiah, S. MurC ligase of multi-drug resistant Salmonella Typhi can be inhibited by novel Curcumin derivative: Evidence from molecular docking and dynamics simulations. Int. J. Biochem. Cell Biol. 151, 106279 (2022).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"15030_CR97","doi-asserted-by":"publisher","first-page":"146","DOI":"10.2174\/157340911795677602","volume":"7","author":"X-Y Meng","year":"2012","unstructured":"Meng, X.-Y., Zhang, H.-X., Mezei, M. & Cui, M. Molecular docking: A powerful approach for structure-based drug discovery. Curr. Comput. Aided-Drug Des. 7, 146\u2013157 (2012).","journal-title":"Curr. Comput. Aided-Drug Des."},{"key":"15030_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fchem.2023.1264808","volume":"11","author":"UC Ogbodo","year":"2023","unstructured":"Ogbodo, U. C. et al. Computational identification of potential inhibitors targeting cdk1 in colorectal cancer. Front. Chem. 11, 1\u201317 (2023).","journal-title":"Front. Chem."},{"key":"15030_CR99","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","volume":"58","author":"DEV Pires","year":"2015","unstructured":"Pires, D. E. V., Blundell, T. L. & Ascher, D. B. pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J. Med. Chem. 58, 4066\u20134072 (2015).","journal-title":"J. Med. Chem."},{"key":"15030_CR100","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1021\/jm0306430","volume":"47","author":"RA Friesner","year":"2004","unstructured":"Friesner, R. A. et al. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J. Med. Chem. 47, 1739\u20131749 (2004).","journal-title":"J. Med. Chem."},{"key":"15030_CR101","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1021\/acs.jctc.5b00864","volume":"12","author":"E Harder","year":"2016","unstructured":"Harder, E. et al. OPLS3: A force field providing broad coverage of drug-like small molecules and proteins. J. Chem. Theory Comput. 12, 281\u2013296 (2016).","journal-title":"J. Chem. Theory Comput."},{"key":"15030_CR102","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/vjch.202200135","volume":"61","author":"BT Tung","year":"2023","unstructured":"Tung, B. T., Son, N. N., Kim, N. B., Khanh, D. T. H. & Minh, P. H. In silico screening of alkaloids as potential inhibitors of HER2 protein for breast cancer treatment. Vietnam J. Chem. 61, 308\u2013317 (2023).","journal-title":"Vietnam J. Chem."},{"key":"15030_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.imu.2024.101522","volume":"48","author":"NH Siddiquee","year":"2024","unstructured":"Siddiquee, N. H. et al. Insights into novel inhibitors intending HCMV protease a computational molecular modelling investigation for antiviral drug repurposing. Inform. Med. Unlocked 48, 101522 (2024).","journal-title":"Inform. Med. Unlocked"},{"key":"15030_CR104","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2024.139924","volume":"1321","author":"MEK Talukder","year":"2025","unstructured":"Talukder, M. E. K. et al. Molecular docking, QSAR, and simulation analyses of EGFR-targeting phytochemicals in non-small cell lung cancer. J. Mol. Struct. 1321, 139924 (2025).","journal-title":"J. Mol. Struct."},{"key":"15030_CR105","doi-asserted-by":"publisher","first-page":"W257","DOI":"10.1093\/nar\/gky318","volume":"46","author":"P Banerjee","year":"2018","unstructured":"Banerjee, P., Eckert, A. O., Schrey, A. K. & Preissner, R. ProTox-II: a webserver for the prediction of toxicity of chemicals. Nucleic Acids Res. 46, W257\u2013W263 (2018).","journal-title":"Nucleic Acids Res."},{"key":"15030_CR106","doi-asserted-by":"publisher","first-page":"7731","DOI":"10.1039\/c3cp00116d","volume":"15","author":"F Godschalk","year":"2013","unstructured":"Godschalk, F., Genheden, S., S\u00f6derhjelm, P. & Ryde, U. Comparison of MM\/GBSA calculations based on explicit and implicit solvent simulations. Phys. Chem. Chem. Phys. 15, 7731\u20137739 (2013).","journal-title":"Phys. Chem. Chem. Phys."},{"key":"15030_CR107","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.ejmech.2012.10.024","volume":"58","author":"M Sgobba","year":"2012","unstructured":"Sgobba, M., Caporuscio, F., Anighoro, A., Portioli, C. & Rastelli, G. Application of a post-docking procedure based on MM-PBSA and MM-GBSA on single and multiple protein conformations. Eur. J. Med. Chem. 58, 431\u2013440 (2012).","journal-title":"Eur. J. Med. Chem."},{"key":"15030_CR108","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1501240","volume":"2","author":"D Chen","year":"2016","unstructured":"Chen, D. et al. Regulation of protein-ligand binding affinity by hydrogen bond pairing. Sci. Adv. 2, e1501240 (2016).","journal-title":"Sci. Adv."},{"key":"15030_CR109","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","volume":"10","author":"S Genheden","year":"2015","unstructured":"Genheden, S. & Ryde, U. The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities. Expert Opin. Drug Discov. 10, 449\u2013461 (2015).","journal-title":"Expert Opin. Drug Discov."},{"key":"15030_CR110","doi-asserted-by":"publisher","first-page":"6661191","DOI":"10.1155\/2021\/6661191","volume":"2021","author":"A Majeed","year":"2021","unstructured":"Majeed, A., Hussain, W., Yasmin, F., Akhtar, A. & Rasool, N. Virtual screening of phytochemicals by targeting HR1 domain of SARS-CoV-2 S protein: Molecular docking, molecular dynamics simulations, and DFT studies. Biomed Res. Int. 2021, 6661191 (2021).","journal-title":"Biomed Res. Int."},{"key":"15030_CR111","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-022-05621-0","volume":"12","author":"A Samad","year":"2022","unstructured":"Samad, A., Huq, M. A. & Rahman, M. S. Bioinformatics approaches identified dasatinib and bortezomib inhibit the activity of MCM7 protein as a potential treatment against human cancer. Sci. Rep. 12, 1\u201316 (2022).","journal-title":"Sci. Rep."},{"key":"15030_CR112","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3934\/biophy.2022018","volume":"9","author":"R Rijal","year":"2022","unstructured":"Rijal, R., Lamichhane, H. P. & Pudasainee, K. Molecular structure, homo-lumo analysis and vibrational spectroscopy of the cancer healing pro-drug temozolomide based on dft calculations. AIMS Biophys. 9, 208\u2013220 (2022).","journal-title":"AIMS Biophys."},{"key":"15030_CR113","doi-asserted-by":"publisher","DOI":"10.1016\/j.puhip.2021.100157","volume":"2","author":"SK Mondal","year":"2021","unstructured":"Mondal, S. K., Khan, A. G., Ali, M. M., Ahamed, M. K. & Ahmed, K. Quality of life among Bangladeshi Youth during the early stage of the COVID-19 pandemic: A single-site survey. Public Heal. Pract. 2, 100157 (2021).","journal-title":"Public Heal. Pract."},{"key":"15030_CR114","doi-asserted-by":"publisher","DOI":"10.1016\/j.mex.2023.102537","volume":"12","author":"ST Quayum","year":"2024","unstructured":"Quayum, S. T. et al. Exploring the effectiveness of flavone derivatives for treating liver diseases: Utilizing DFT, molecular docking, and molecular dynamics techniques. MethodsX 12, 102537 (2024).","journal-title":"MethodsX"},{"key":"15030_CR115","doi-asserted-by":"publisher","first-page":"8440","DOI":"10.1073\/pnas.83.22.8440","volume":"83","author":"RG Pearson","year":"1986","unstructured":"Pearson, R. G. Absolute electronegativity and hardness correlated with molecular orbital theory. Proc. Natl. Acad. Sci. 83, 8440\u20138441 (1986).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"15030_CR116","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1021\/ci000383k","volume":"40","author":"VV Poroikov","year":"2000","unstructured":"Poroikov, V. V., Filimonov, D. A., Borodina, Y. V., Lagunin, A. A. & Kos, A. Robustness of biological activity spectra predicting by computer program PASS for noncongeneric sets of chemical compounds. J. Chem. Inf. Comput. Sci. 40, 1349\u20131355 (2000).","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"15030_CR117","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1021\/jm0010670","volume":"44","author":"S Anzali","year":"2001","unstructured":"Anzali, S. et al. Discriminating between drugs and nondrugs by prediction of activity spectra for substances (PASS). J. Med. Chem. 44, 2432\u20132437 (2001).","journal-title":"J. Med. Chem."},{"key":"15030_CR118","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1007\/s11172-017-1954-x","volume":"66","author":"DS Druzhilovskiy","year":"2017","unstructured":"Druzhilovskiy, D. S. et al. Computational platform Way2Drug: From the prediction of biological activity to drug repurposing. Russ. Chem. Bull. 66, 1832\u20131841 (2017).","journal-title":"Russ. Chem. Bull."},{"key":"15030_CR119","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1093\/bioinformatics\/16.8.747","volume":"16","author":"A Lagunin","year":"2000","unstructured":"Lagunin, A., Stepanchikova, A., Filimonov, D. & Poroikov, V. PASS: Prediction of activity spectra for biologically active substances. Bioinformatics 16, 747\u2013748 (2000).","journal-title":"Bioinformatics"},{"key":"15030_CR120","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fchem.2024.1407331","volume":"12","author":"MEK Talukder","year":"2024","unstructured":"Talukder, M. E. K. et al. Cheminformatics-based identification of phosphorylated RET tyrosine kinase inhibitors for human cancer. Front. Chem. 12, 1\u201318 (2024).","journal-title":"Front. Chem."},{"key":"15030_CR121","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1021\/acscombsci.0c00058","volume":"22","author":"B Goyal","year":"2020","unstructured":"Goyal, B. & Goyal, D. Targeting the dimerization of the main protease of coronaviruses: A potential broad-spectrum therapeutic Strategy. ACS Comb. Sci. 22, 297\u2013305 (2020).","journal-title":"ACS Comb. Sci."},{"key":"15030_CR122","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s12325-022-02347-3","volume":"40","author":"A Corvino","year":"2023","unstructured":"Corvino, A. et al. Phloroglucinol-derived medications are effective in reducing pain and spasms of urinary and biliary tracts: Results of Phase 3 multicentre, open-label, randomized, comparative studies of clinical effectiveness and safety. Adv. Ther. 40, 619\u2013640 (2023).","journal-title":"Adv. Ther."},{"key":"15030_CR123","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1080\/07388551.2022.2160695","volume":"44","author":"G Peron","year":"2024","unstructured":"Peron, G. et al. Antiviral and antibacterial properties of phloroglucinols: A review on naturally occurring and (semi)synthetic derivatives with potential therapeutic interest. Crit. Rev. Biotechnol. 44, 319\u2013336 (2024).","journal-title":"Crit. Rev. Biotechnol."},{"key":"15030_CR124","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1080\/13880209.2022.2088809","volume":"60","author":"YT Chang","year":"2022","unstructured":"Chang, Y. T. et al. Anti-EMT and anti-fibrosis effects of protocatechuic aldehyde in renal proximal tubular cells and the unilateral ureteral obstruction animal model. Pharm. Biol. 60, 1198\u20131206 (2022).","journal-title":"Pharm. Biol."},{"key":"15030_CR125","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.3390\/md9071273","volume":"9","author":"M Liu","year":"2011","unstructured":"Liu, M., Hansen, P. E. & Lin, X. Bromophenols in marine algae and their bioactivities. Mar. Drugs 9, 1273\u20131292 (2011).","journal-title":"Mar. Drugs"},{"key":"15030_CR126","doi-asserted-by":"publisher","DOI":"10.1002\/med.22062","author":"PP Pagare","year":"2024","unstructured":"Pagare, P. P. et al. The antisickling agent, 5-hydroxymethyl-2-furfural: Other potential pharmacological applications. Med. Res. Rev. https:\/\/doi.org\/10.1002\/med.22062 (2024).","journal-title":"Med. Res. Rev."},{"key":"15030_CR127","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s12192-010-0238-2","volume":"16","author":"MM Li","year":"2010","unstructured":"Li, M. M. et al. The protective role of 5-HMF against hypoxic injury. Cell Stress Chaperones 16, 267 (2010).","journal-title":"Cell Stress Chaperones"},{"key":"15030_CR128","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1021\/np50126a007","volume":"58","author":"KL Erickson","year":"1995","unstructured":"Erickson, K. L., Beutler, J. A., Gray, G. N., Cardellina, J. H. & Boyd, M. R. Majapolene a, a cytotoxic peroxide, and related sesquiterpenes from the red alga Laurencia majuscula. J. Nat. Prod. 58, 1848\u20131860 (1995).","journal-title":"J. Nat. Prod."},{"key":"15030_CR129","doi-asserted-by":"publisher","first-page":"9916","DOI":"10.1021\/jf2022447","volume":"59","author":"K Li","year":"2011","unstructured":"Li, K., Li, X. M., Gloer, J. B. & Wang, B. G. Isolation, characterization, and antioxidant activity of bromophenols of the marine red alga Rhodomela confervoides. J. Agric. Food Chem. 59, 9916\u20139921 (2011).","journal-title":"J. Agric. Food Chem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15030-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15030-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15030-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T10:03:42Z","timestamp":1759313022000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15030-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":129,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["15030"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-15030-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]},"assertion":[{"value":"14 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author(s) declared no potential conflicts of interest with respect to the research, authorship, and\/or publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This research involves no animal model. So, this is not applicable for this.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}}],"article-number":"34162"}}